Protagonist Therapeutics Inc (PTGX)

Revenue

$281.99M

TTM · Period ending: · USD

PTGX logo

PTGX Revenue

Latest reported$281.99M
PTGX TTM Revenue ($0.00 → $281.99M)
High-resolution chart · PNG

PTGX revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Protagonist Therapeutics Inc Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
281,992,000
74,063,000
46,016,000
209,217,000
209,180,000
207,801,000
434,433,000
323,795,000
319,120,000
314,953,000
60,000,000
0
0
859,000
26,581,000
35,198,000
45,484,000
46,890,000
27,357,000
24,390,000
27,218,000
31,170,000
28,628,000
25,697,000
16,724,000
2,318,000
231,000
-135,000
1,841,000
21,704,000
30,925,000
39,854,000
42,518,000
30,844,000
20,063,000
8,781,000
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.